Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19

NCT04797975 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The sponsor decided to withdraw this study

Conditions

Interventions

Sponsor

Kiadis Pharma